Lots More Information

Resources

• www.nimh.nih.gov -- National Institute of Mental Health
• www.bpkids.org -- Child & Adolescent Bipolar Foundation
• www.dbsalliance.org -- Depression and Bipolar Support Alliance
• www.nami.org -- National Alliance for the Mentally Ill
• www.nmha.org -- National Mental Health Association
• www.aabt.org -- Association for the Advancement of Behavior Therapy
• www.psych.org -- The American Psychiatric Association
• www.aacap.org -- American Academy of Child and Adolescent Psychiatry
• www.stepbd.org -- Enrollment in the STEP-BD clinical trial

References

Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162(7):1351-1360.

Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62(9):996-1004.

McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet. 2005;77(4):582-595.

Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: Implications for clinical management during late pregnancy. Am J Psychiatry. 2005;162(11):2162-2170.

Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, Brzustowicz LM. Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med. 2005;2(10):e263.

---

Review Date: 12/13/2005
Reviewed By: Harvey Simon, MD, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital